Hasten Biopharmaceutical Co., Ltd.
PrivateLast Round
Series A
Apr 20, 2023
Total Funding Raised
$315M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Hasten Biopharmaceutical Co., Ltd. is a biopharmaceutical company that integrates research, development, production, and commercialization of therapeutics for chronic and critical care diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hasten Biopharmaceutical Co., Ltd. Comparables
Compare Hasten Biopharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuance Pharma | 80% | |
| China Medical System Holdings Limited | 77% | |
| Shanghai Pioneer Holding Ltd | 77% |
Hasten Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 20, 2023 |
Key People
Founding team and executive leadership
Hasten Biopharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CBC Group | Series A |
| Mubadala Investment Company | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 82% MoM.
- Jul 14, 2025
Grew 39% QoQ, from 33 to 46 employees.
Hasten Biopharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hasten Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Hasten Biopharmaceutical Co., Ltd. a public or private company?
Hasten Biopharmaceutical Co., Ltd. is a private company.
What is the current stock price of Hasten Biopharmaceutical Co., Ltd.?
Hasten Biopharmaceutical Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Hasten Biopharmaceutical Co., Ltd. worth (valuation)?
Valuation information for Hasten Biopharmaceutical Co., Ltd. is not publicly available.
Can I buy Hasten Biopharmaceutical Co., Ltd. stock?
Hasten Biopharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hasten Biopharmaceutical Co., Ltd.'s last funding round?
Hasten Biopharmaceutical Co., Ltd.'s most recent funding round was Series A on April 20, 2023.
Who are the main investors in Hasten Biopharmaceutical Co., Ltd.?
Key investors in Hasten Biopharmaceutical Co., Ltd. include CBC Group, Mubadala Investment Company.
Will Hasten Biopharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Hasten Biopharmaceutical Co., Ltd..
How can I track Hasten Biopharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hasten Biopharmaceutical Co., Ltd.'s secondary market activity and sign up for updates.